Stock AnalizAlign Technology Inc. ALGN
Industrial Specialties · IPO 2001 · data as of November 13, 2026
Align Technology Inc. (ALGN) is a healthcare company listed in the US with a market value of about $11.9B. In the twelve months to September 30, 2026 it had revenue of $4.2B and net income of $492M, a net margin of 11.8%.
Its overall Stock Analiz score is 3.0 out of 5 (average). The strongest part is financial health (5/5); the weakest is value (2/5).
Key numbers: a P/E of 24.5, a price to free cash flow of 19.7, 5-year revenue growth of 10% a year, a 5-year average ROIC of 12%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 44% below the current price.
Score: 3.0 / 5
Checks passed
- P/E below 25
- P/FCF below 20
- 3-year free cash flow growth above 10% a year
- Strong R&D investment or growth above 20%
- 5-year revenue growth above 8% a year
- 5-year average ROIC above 12%
- Profitable 5 years in a row
- More cash than debt, or low debt to equity
Checks not passed
- P/E below the industry median
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
- 5-year EPS growth above 10% a year
- ROE above 15%
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.2B | $4.0B | $4.0B | $3.9B | $3.7B | $4.0B | $2.5B | $2.4B | $2.0B | $1.5B | $1.1B |
| Net income | $492M | $410M | $421M | $445M | $362M | $772M | $1.8B | $443M | $400M | $231M | $190M |
| Free cash flow | $602M | $491M | $623M | $608M | $277M | $771M | $507M | $598M | $331M | $243M | $177M |
| EPS (diluted) | $6.86 | $5.65 | $5.62 | $5.81 | $4.61 | $9.69 | $22.41 | $5.53 | $4.92 | $2.83 | $2.33 |
| Net margin | 11.8% | 10.2% | 10.5% | 11.5% | 9.7% | 19.5% | 71.8% | 18.4% | 20.3% | 15.7% | 17.6% |
| ROIC | — | 9.2% | 10.6% | 11.9% | 10.4% | 19.9% | 9.2% | 30.9% | 32.6% | 19.7% | 19.7% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 14 analysts is $185.79, 10% above the current price; targets range from $160.00 to $210.00; the consensus rating is “Buy”; expected EPS is $11.13 for the fiscal year ending December 31, 2026.
Frequently asked questions
What is Align Technology’s P/E ratio?
About 24.5, based on the last twelve months of diluted earnings per share (forward P/E about 14.1).
Is Align Technology stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 44% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Align Technology pay a dividend?
Not currently.
Is Align Technology a good stock to buy?
We do not give buy or sell advice. Align Technology scores 3.0 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.